Standout Papers

A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo 2019 2026 2021 2023 424
  1. A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo (2019)
    Longchuan Bai, Haibin Zhou et al. Cancer Cell

Immediate Impact

1 by Nobel laureates 71 standout
Sub-graph 1 of 20

Citing Papers

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Artificial intelligence in drug development
2025 Standout
3 intermediate papers

Works of Renqi Xu being referenced

A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
2019 Standout
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
2019

Author Peers

Author Last Decade Papers Cites
Renqi Xu 530 372 18 166 9 692
Clara Lemos 448 296 7 196 10 688
Roberta Pireddu 456 237 16 125 14 701
Tadakazu Akiyama 555 297 43 114 17 817
Kelly Davison 629 138 6 270 13 812
Yi He Ling 575 378 23 110 14 845
S.H. Rosenberg 355 180 20 140 12 583
MV Blagosklonny 546 185 15 89 9 771
M Wang 497 224 15 196 14 738
Bing An 500 278 8 57 13 641
Mary Gleason-Guzman 583 229 8 65 15 805

All Works

Loading papers...

Rankless by CCL
2026